Cigna Group Executive Neville Everett Sells 617 Shares for $175,000
Everett disposed of 11% of his direct equity holdings under a pre-arranged Rule 10b5-1 trading plan, leaving a stake valued at $1.45 million.
Executive Neville Everett of The Cigna Group (CI) transferred ownership of 617 shares on 2026-09-03, according to regulatory filings. The sale value equated to $284.05 per share, based on the average price calculated by the SEC Form 4. The transaction resulted in a post-trade market valuation of $286.26 per share, as of the closing bell on 2026-09-03.
The executive's decision to sell shares was conducted under a pre-established trading plan that was enacted on 2026-06-02. This plan governs the timing of equity sales, thereby eliminating any discretionary timing decisions. After selling 617 shares, Neville Everett retains a stake of 5,053 shares, equating to a market value of $1.45 million at the market close price of $286.26.
This equity sale is relatively minor compared to the executive's overall ownership. Despite the sale occurring during a period when the company's stock experienced a one-year total return of -2.7%, the executive's decision is deemed inconsequential for investors. The Cigna Group operates through two main segments: Evernorth, specializing in coordinated and specialized health solutions, and its core insurance operations, offering various insurance products in the United States.
The company's revenue is derived from premiums, pharmacy benefit management, care coordination, and benefits administration fees. Cigna serves a broad clientele, from employers and health plans to individual consumers, positioning itself as a comprehensive healthcare solutions provider. The company boasts a substantial market capitalization and revenue, reflecting its significant presence in the healthcare sector.
The company's integrated business model, combining health insurance with pharmacy services and care management, enhances operational efficiencies and delivers coordinated care. Despite a slight decline in stock price, Cigna demonstrated resilience with a substantial year-over-year revenue growth of nearly 8% and maintained a strong operating margin of 3.5%.
Analysts project continued earnings growth, with a forward price-to-earnings ratio of 8.7x. While Cigna Group was not included in The Motley Fool Stock Advisor's latest top 10 list, it continues to perform in line with its historical trends.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
